Patented Technology Aims for Zero Missed Heart Disease Diagnoses; Cocolomil to Present Heart Disease Risk Detection Efforts at Japan's Largest Invitation-Only Conference 'B Dash Camp Pitch Arena'
NQ Score
44/100
N1 Content Completeness
4
AI Summary (NQ-processed)
Cocolomil Inc. has been selected as one of the 12 finalists for the 'Pitch Arena' pitch contest at 'B Dash Camp 2026 Spring in Sapporo,' Japan's largest invitation-only conference. As the only healthcare company among over 150 entries, Cocolomil will present its efforts to achieve zero missed heart disease diagnoses through an integrated system from early detection at home to reliable medical connection, based on its proprietary patented technology.